Nebulised lidocaine before nasogastric tube insertion reduced patient discomfort but increased risk of nasal bleeding
Q Does administration of nebulised lidocaine (lignocaine) before nasogastric tube (NGT) insertion reduce patient discomfort?
METHODS
Design:
randomised, placebo controlled trial.
Allocation:
concealed.
Blinding:
blinded {patients, clinicians, data collectors, outcome assessors, data analysts, and manuscript writers}*.
Follow up period:
after NGT was secured.
Setting:
emergency departments (EDs) of 2 large university hospitals in Australia.
Patients:
50 patients >18 years of age (50% men) who required a NGT as part of their ED treatment. Exclusion criteria were inability to assess pain (altered mental state, language barrier, or dementia), systolic blood pressure <100 mm Hg, emergency indication for NGT insertion (eg, major trauma), allergy to lidocaine, concurrent administration of intravenous lidocaine, pregnancy, weight <50 kg, pre-existing gag reflex impairment, or reactive airways disease.
Intervention:
lidocaine, 400 mg, 4 ml of 10% solution (n = 29) or …
